Print Page

Other safety alerts

 
Canada: Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks
 
Health Canada is warning the public of seized unauthorized injectable peptide drugs from Canada Peptide. The products were being sold via the company's website. Peptide drugs affect the body's functions and are often used for bodybuilding, anti-aging, or enhancing athletic performance. Injectable peptides are regulated as prescription drugs in Canada. The affected products are:

• AOD9604
• ARA 290
• Bremelanotide
• Bronchogen
• BPC-157
• CJC-1295
• Cortagen
• DSIP
• Epitalon
• GHK, GHK-Cu
• GHRP 2
• GHRP 6
• GLP-1 (7-37)
• Gonadorelin
• Hexarelin
• HGH, HGH Fragment
• Humanine
• Ipamoreline
• Kisspeptin
• KK-23
• Livagen
• LL-37
• Melanotan 1
• Melanotan II
• NR-7
• Ovagen
• Pal-GHK
• Pinealon
• PNC-27
• Prostamax
• QS-13
• Retatrutide
• Selank
• Semax
• Sermorelin
• SS-31
• Tesamorelin
• Thymosin alpha
• Thymosin-β4 (TB4 or TB-500)
• Tirzepatide
• Vilon
• VIP

Health Canada has not authorized any of the products that were seized or sold on the company's website, which means that they have not been assessed for safety, efficacy, and quality. Selling unauthorized drugs is illegal in Canada.

Prescription drugs should only be used under the care of a healthcare professional because they are used to treat specific conditions and may cause serious side effects. Unauthorized injectable drugs may:
• Cause infection, allergic reactions, and other poor outcomes.
• Interact with other medications an individual might be taking.
• Contain high-risk ingredients, additives, or contaminants that may or may not be listed on the label.
• Not have been manufactured or stored safely.

Please refer to the following website in Health Canada for details: http://recalls-rappels.canada.ca/en/alert-recall/unauthorized-injectable-peptide-drugs-seized-and-sold-canada-peptide-may-pose-serious

In Hong Kong, the above products are not registered pharmaceutical products.

Ends/Saturday, Aug 2, 2025
Issued at HKT 12:00
 
 
back